Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (585)	6/9/2004 3:59:14 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

Looking at some of the best performing Biotechs lately. (The market in general has not been too good.<g>) ACEL Had a 100% gain since mid-April. Its ONCONASE is on a PIII for patients with unresectable malignant mesothelioma. Onconase o ranpirnase is a an amphibian ribonuclease,it is the smallest known among the family of pancreatic ribonuclease which has been isolated from the eggs of the leopard frog.It allegedly isn't an indiscriminate cytotoxic agent, but affects primarily malignant cells, growing at a rapid pace. The insiders reportedly hold around 11% of the 29M shares out. The company is stranded for cash, the CR is around 0.9 and BKV a negative 0.004 but the average daily volume is more than 200K <g> bigcharts.marketwatch.com bigcharts.marketwatch.com Bernard